Zhihong Li

9PUBLICATIONS
7CO-AUTHORS
Injury preventionFree radical chemistryChemical and thermal processes in energy and combustionMechanobiologyAerodynamics (excl. hypersonic aerodynamics)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (9)

|May 02, 2026
A Near-Infrared Photoactivatable, Brain-Penetrant Prodrug of the Prolyl Hydroxylase Inhibitor Vadadustat for Neuroprotection in Ischemic Stroke.

|May 09, 2025
Light-Induced, Lysine-Targeting Irreversible Covalent Inhibition of the Human Oxygen Sensing Hydroxylase Factor Inhibiting HIF (FIH).

Yue Wu, Zhihong Li, Samanpreet Kaur

|Oct 21, 2024
Discovery of ZG-2305, an Orally Bioavailable Factor Inhibiting HIF Inhibitor for the Treatment of Obesity and Fatty Liver Disease.

Yue Wu, Zewei Zhang, Haiping Cai

|Oct 28, 2021
Discovery of a Potent and Orally Bioavailable Hypoxia-Inducible Factor 2α (HIF-2α) Agonist and Its Synergistic Therapy with Prolyl Hydroxylase Inhibitors for the Treatment of Renal Anemia.

Yancheng Yu, Fulai Yang, Quanwei Yu

|May 24, 2021
Inhibition of the Oxygen-Sensing Asparaginyl Hydroxylase Factor Inhibiting Hypoxia-Inducible Factor: A Potential Hypoxia Response Modulating Strategy.

Yue Wu, Zhihong Li, Michael A McDonough

|Aug 14, 2020
Discovery of Clinical Candidate (5-(3-(4-Chlorophenoxy)prop-1-yn-1-yl)-3-hydroxypicolinoyl)glycine, an Orally Bioavailable Prolyl Hydroxylase Inhibitor for the Treatment of Anemia.

Xiaojin Zhang, Yonghua Lei, Tianhan Hu

Pageof 2

Frequent Collaborators

9 joint publications

Xiaojin Zhang

4 joint publications

Qidong You

4 joint publications

Fulai Yang

3 joint publications

Christopher J Schofield